Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy

International Journal of Infectious Diseases

Volumn 17, Issue 10, 2013, Pages

  Bunupuradah, Torsak ^a,b   Kariminia, Azar ^b   Chan, Kwai Cheng ^c   Ramautarsing, Reshmie ^a,d   Huy, Bui Vu ^e   Han, Ning ^f   Nallusamy, Revathy ^c   Hansudewechakul, Rawiwan ^g   Saphonn, Vonthanak ^h   Sirisanthana, Virat ⁱ   Chokephaibulkit, Kulkanya ^j   Kurniati, Nia ^k   Kumarasamy, Nagalingeswaran ^l   Yusoff, Nik Khairulddin Nik ^m   Razali, Kamarul ⁿ   Fong, Siew Moy ^o   Sohn, Annette H ^p   Lumbiganon, Pagakrong ^q  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c HOSPITAL PULAU PINANG   (Malaysia)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e NATIONAL HOSPITAL OF PEDIATRICS   (Viet Nam)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g CHIANGRAI PRACHANUKROH HOSPITAL   (Thailand)

^h National Pediatric Hospital   (Cambodia)

ⁱ CHIANG MAI UNIVERSITY   (Thailand)

^j MAHIDOL UNIVERSITY   (Thailand)

^k CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^l YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^m Hospital Raja Perempuan Zainab II   (Malaysia)

ⁿ HOSPITAL KUALA LUMPUR   (Malaysia)

^o Hospital Likas   (Malaysia)

^p TREAT Asia/amfAR The Foundation for AIDS Research   (Thailand)

^q KHON KAEN UNIVERSITY   (Thailand)

more..

Author keywords

Anemia; Antiretroviral therapy; Asia; Pediatric HIV

Indexed keywords

EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS STAVUDINE; VIRUS RNA;

ANEMIA; ASIAN; CHILD; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SHORT SURVEY; TREATMENT DURATION; WORLD HEALTH ORGANIZATION;

ANEMIA; ANTIRETROVIRAL THERAPY; ASIA; PEDIATRIC HIV;

ANEMIA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA, SOUTHEASTERN; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; KAPLAN-MEIER ESTIMATE; MALE; RISK FACTORS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 84883783112     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.04.006     Document Type: Short Survey

References (16)

1. Calis J.C., van Hensbroek M.B., de Haan R.J., Moons P., Brabin B.J., Bates I. HIV-associated anemia in children: a systematic review from a global perspective. AIDS 2008, 22:1099-1112.
2. Huffam S.E., Srasuebkul P., Zhou J., Calmy A., Saphonn V., Kaldor J.M., et al. Prior antiretroviral therapy experience protects against zidovudine-related anaemia. HIV Med 2007, 8:465-471.
3. Volberding P.A., Levine A.M., Dieterich D., Mildvan D., Mitsuyasu R., Saag M. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 2004, 38:1454-1463.
4. Semba R.D., Martin B.K., Kempen J.H., Thorne J.E., Wu A.W. The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 2005, 165:2229-2236.
5. Belperio P.S., Rhew D.C. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004, 116(Suppl 7A):27S-43S.
6. Sutcliffe C.G., van Dijk J.H., Munsanje B., Hamangaba F., Siniwymaanzi P., Thuma P.E., et al. Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: a cohort study. PLoS One 2012, 6:e29294.
7. Kariminia A., Chokephaibulkit K., Pang J., Lumbiganon P., Hansudewechakul R., Amin J., et al. Cohort profile: the TREAT Asia pediatric HIV observational database. Int J Epidemiol 2010, 40:15-24.
8. World Health Organization. Antiretroviral therapy for infants and children 2008. Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting, WHO Headquarters, Geneva, Switzerland, April 10-11, 2008.
9. National Institute of Allergy and Infectious Disease. The Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events version 1.0, December 2004; clarification August 2009. Available at (accessed February 14, 2013). http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf.
10. World Health Organization. WHO growth chart 2006. Available at: (accessed 8 September 2012). http://www.who.int/growthref/en/.
11. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Mei Z., et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002, 246:1-190.
12. The World Bank. Data Countries and Economies. (accessed 13 February 2013). http://data.worldbank.org/income-level/LIC.
13. Shet A., Mehta S., Rajagopalan N., Dinakar C., Ramesh E., Samuel N.M., et al. Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr 2009, 9:37.
14. Ssali F., Stohr W., Munderi P., Reid A., Walker A.S., Gibb D.M., et al. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antivir Ther 2006, 11:741-749.
15. World Health Organization Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach 2010 revision 2010, WHO, Geneva.
16. Kosalaraksa P., Bunupuradah T., Vonthanak S., Wiangnon S., Hansudewechakul R., Vibol U., et al. Prevalence of anemia and underlying iron status in naive antiretroviral therapy HIV-infected children with moderate immune suppression. AIDS research and human retroviruses 2012 Dec 28, 12:1679-1686.